Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes
about
An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements.Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: a comparison with dexamethasone.The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancerPPARs in the Renal Regulation of Systemic Blood PressureInvolvement of PPAR nuclear receptors in tissue injury and wound repairGene expression in visceral and subcutaneous adipose tissues.Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancerPPARgamma and metabolism: insights from the study of human genetic variants.The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance.PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNSThe potential of antidiabetic thiazolidinediones for anticancer therapy.Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approachesPeroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.The effect of n-3 long chain fatty acids supplementation on plasma peroxisome proliferator activated receptor gamma and thyroid hormones in obesity.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.The adipose renin-angiotensin system: role in cardiovascular disease.Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in ObesityThe prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity.Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivoA novel intronic peroxisome proliferator-activated receptor gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes.The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.The regulation of uncoupling protein-2 gene expression by omega-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor beta.Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells.Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster.Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma.[Against insulin resistance. Insulin sensitizers].Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma2.Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats.Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones.Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expression.Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis.Functional Analysis of Promoters from Three Subtypes of the PI3K Family and Their Roles in the Regulation of Lipid Metabolism by Insulin in Yellow Catfish Pelteobagrus fulvidraco.PPARγ activation regulates lipid droplet formation and lactate production in rat Sertoli cells.
P2860
Q30349739-93D1794F-9395-4084-A5E2-C05A6000B642Q32064681-C6CCC23F-61D2-4AAC-98DE-DB3F0935C02CQ33770842-1D8D9D3A-29EB-4CE8-ADD4-E8DF4CE08A55Q33960908-06194292-6DD5-4D39-8854-3B815371AF69Q34416422-4FC3230B-9DB6-449F-B14C-F6E3D803EB77Q34454561-780E690A-6741-408D-A0A7-FAF50E2F4E12Q34591803-108C67C9-FD01-44F6-ACDB-0D4526FB33CBQ35168034-AC686D55-D570-4398-90D1-D42DC41078E6Q35200033-63E7F66A-72AD-4938-A24F-C9DABA525980Q36011824-6E154FFD-0372-4838-B168-FF854515D6DAQ36465006-515A3864-DFD2-450B-9B57-DA072B07181FQ36556337-FF88F3B6-DAB8-4C00-8FBA-1A69A2A55EBFQ36568732-6752F10C-C625-4523-BA19-BBAD3D2DEDE6Q36608474-9FE72E0F-724B-41CC-864A-04850D3A7E1DQ36964693-8E8EF007-CD12-44FB-86B1-A8D64998667FQ36973992-68512146-050F-4765-8C62-DE6E1EA484EDQ37157524-15567DD4-DA08-49CC-9B15-0F4E7206FFC7Q37357429-8B926ED9-DD1C-4B94-A29C-803894037BD6Q37435676-06F9B6E4-7E10-40F0-8BD7-9FC5A73826ADQ37712484-5A282E9A-1512-4D39-9897-560A79CE15CBQ38299766-A39C8316-FDD5-448D-B58A-8D9A9FDF4242Q39209941-1CC3B8DB-0796-46F3-A070-1B18272B7EF4Q40626700-E4452CD6-2AB5-4BAB-AFD7-A4B36A8FCFCAQ40812851-8C20AA08-686A-4BAF-A7D8-577F2864EC1AQ42818947-CD06F5BB-A90B-4FA9-A0CB-37C4415966AEQ43559363-35DB3476-9D81-4412-AD3B-4B0DF103F40AQ43696251-7CE1F95B-BC3B-4ECD-927C-CFA20560BE9EQ43754126-B535CBB2-78D8-42C1-BD18-19B6597BA3C0Q44016915-780CF501-88F2-4B48-BEEB-C0FD1712D791Q44021600-2AC7CFC1-BE52-4772-9E19-D4055F66AB98Q44032476-D980690C-1C81-4C5A-854A-0A0A2E92136EQ44770906-559D9DEA-D1FD-4491-9A72-05C9855C5CF8Q45248677-407DF6B9-F227-4B80-8976-0C56F6D458FBQ46433354-655899A3-2A42-400E-9A8C-B5BDC8773D30Q46758003-907DB8FD-19D4-42BD-BD03-247222CD6E72Q47653315-DBF8BDDB-9BD7-4CBB-B1D7-359CAAF0A495Q48235777-2A42AB0E-27F3-403D-91E2-53A50820337DQ50709371-E6671F8E-BCE5-46AF-9CF1-00D5856B8629
P2860
Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Regulation of gene expression ...... BRL 49653) in human adipocytes
@ast
Regulation of gene expression ...... BRL 49653) in human adipocytes
@en
Regulation of gene expression ...... BRL 49653) in human adipocytes
@nl
type
label
Regulation of gene expression ...... BRL 49653) in human adipocytes
@ast
Regulation of gene expression ...... BRL 49653) in human adipocytes
@en
Regulation of gene expression ...... BRL 49653) in human adipocytes
@nl
prefLabel
Regulation of gene expression ...... BRL 49653) in human adipocytes
@ast
Regulation of gene expression ...... BRL 49653) in human adipocytes
@en
Regulation of gene expression ...... BRL 49653) in human adipocytes
@nl
P50
P356
P1476
Regulation of gene expression ...... BRL 49653) in human adipocytes
@en
P2093
P304
P356
10.1006/BBRC.1999.1657
P407
P577
1999-11-01T00:00:00Z